Clinical Trial Update: Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describing Phase 2/Phase 3 studies evaluating the pleiotropic effects of dapagliflozin in patients with acute coronary syndrome, including…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Diabetes Mellitus
• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Dapagliflozin (Farxiga) (dapagliflozin)

Snippet

Sponsor: University of Sao Paulo | Conditions: Myocardial Infarction, Acute Coronary Syndrome | Phase 2, Phase 3 | Status: RECRUITING